Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04755205 · ClinicalTrials.gov registry record
A Natural History Study of Children and Adults With Olfactory Neuroblastoma
A clinical trial of Esthesioneuroblastoma and Olfactory Neuroblastoma, sponsored by National Cancer Institute (NCI).
- Recruiting
- Registry status
- 525
- Enrollment target
- 1
- Study location
NCT04755205 is a study of Esthesioneuroblastoma and Olfactory Neuroblastoma that is actively recruiting participants, run by National Cancer Institute (NCI). The registered enrollment target is 525 participants, above the 210-participant average among 3 other Esthesioneuroblastoma trials with a reported enrollment target (150% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04755205, a study of Esthesioneuroblastoma and Olfactory Neuroblastoma, is actively recruiting participants, sponsored by National Cancer Institute (NCI).
- RECRUITING
- Registry status
- 525 participants
- Enrollment target
- 1
- Study location
Study Summary
Background: Olfactory neuroblastoma (ONB) is a rare cancer. It grows from tissue in the upper part of the nose cavity, related to the sense of smell and can affect a person s sense of smell. Researchers want to better understand the health problems of people with ONB. This may help them design better treatment and supportive care studies. Objective: To better understand ONB-the course of the disease, tumor characteristics, response to treatments, and management of the treatment. Eligibility: People ages 3 years and older who have ONB. They must enroll in NIH studies #19-C-0016 and #18-DC-0051. Design: Participants will be screened with a medical history and medical record review. Participants do not have to visit NIH. Participants will give a blood sample. They will complete surveys to assess their emotional and physical wellbeing and needs. Leftover tissue from biopsies and surgeries will be collected. Participants will take smell tests. They will smell items and answer questions about them. Participants may take taste tests. They will get plastic taste strips that they will move around their mouth to determine the taste. Participants may have a physical exam. Their performance status may be assessed. Participants may give blood, saliva, urine, and nasal secretion samples. Participants may have computed tomography and/or magnetic resonance imaging scans. Participants may have one or more tumor biopsies. Participants will talk to the research team about the results of their medical record/tests evaluation. The team will recommend how to best manage and treat their disease. Participants may give samples and complete surveys every 12 months. Their medical records will be reviewed every year. They will be monitored for the rest of their life. ...
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 525 participants |
| Start Date | 2022-06-02 |
| Est. Completion | 2029-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04755205
The ClinicalTrials.gov registry entry for NCT04755205 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 525 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 210-participant average among 3 other Esthesioneuroblastoma trials with a reported enrollment target (150% higher). The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Esthesioneuroblastoma appearing as the primary indexed condition, and to 0 interventions.
NCT04755205 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT04755205 about?
NCT04755205 is a clinical study titled "A Natural History Study of Children and Adults With Olfactory Neuroblastoma". Background: Olfactory neuroblastoma (ONB) is a rare cancer. It grows from tissue in the upper part of the nose cavity, related to the sense of smell and can affect a person s sense of smell. Researchers want to better understand the health problems of people with ONB. This may help them design bett...
What is the current status of trial NCT04755205?
This trial is currently recruiting. The enrollment target is 525 participants. The study started on 2022-06-02. Estimated completion is 2029-12-31.
What conditions does trial NCT04755205 study?
This clinical trial studies the following conditions: Esthesioneuroblastoma, Olfactory Neuroblastoma.
Who is sponsoring clinical trial NCT04755205?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04755205 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Esthesioneuroblastoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.